Cite

HARVARD Citation

    Mukai, H. et al. (2016). Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer. Cancer science. 107 (10), pp. 1465-1470. [Online]. 
  
Back to record